Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Beata Żołnowska"'
Autor:
Sebastian Majewski, Adam J. Białas, Adam Barczyk, Halina Batura-Gabryel, Małgorzata Buchczyk, Anna Doboszyńska, Katarzyna Górska, Luiza Grabowska-Skudlarz, Hanna Jagielska-Len, Agnieszka Jarzemska, Ewa Jassem, Dariusz Jastrzębski, Aleksander Kania, Marek Koprowski, Michał Krawczyk, Rafał Krenke, Katarzyna Lewandowska, Barbara Mackiewicz, Magdalena M. Martusewicz-Boros, Janusz Milanowski, Małgorzata Noceń-Piskorowska, Agata Nowicka, Kazimierz Roszkowski-Śliż, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Tomasz Stachura, Małgorzata Tomczak, Witold Tomkowski, Marzena Trzaska-Sobczak, Dariusz Ziora, Beata Żołnowska, Wojciech J. Piotrowski
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 14, p 4635 (2023)
Nintedanib is a disease-modifying agent licensed for the treatment of IPF. Data on Polish experience with nintedanib in IPF are lacking. The present study aimed to describe the safety and efficacy profiles of nintedanib in a large real-world cohort o
Externí odkaz:
https://doaj.org/article/d2097fe1367643529ed87eaa586a7108
Autor:
Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem, Aleksander Kania, Katarzyna Lewandowska, Sebastian Majewski, Magdalena M. Martusewicz-Boros, Wojciech J. Piotrowski, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Marzena Trzaska-Sobczak, Witold Tomkowski, Beata Żołnowska, Rafał Krenke
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Pirfenidone and nintedanib are considered as the standard of care in idiopathic pulmonary fibrosis (IPF), but there is no consensus as to which of these two agents should be regarded as first-line treatment. Objective: To provide real-wor
Externí odkaz:
https://doaj.org/article/f292078d43f34b2ea0136d89cf7f4dc6
Autor:
Beata Żołnowska, Jarosław Sławiński, Mariusz Belka, Tomasz Bączek, Jarosław Chojnacki, Anna Kawiak
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 11, p 9768 (2023)
A series of novel 2-alkythio-4-chloro-N-[imino-(heteroaryl)methyl]benzenesulfonamide derivatives, 8–24, were synthesized in the reaction of the N-(benzenesulfonyl)cyanamide potassium salts 1–7 with the appropriate mercaptoheterocycles. All the sy
Externí odkaz:
https://doaj.org/article/5887284669114f70bbab0b7c3cb804a8
Autor:
Sebastian Majewski, Adam J. Białas, Małgorzata Buchczyk, Paweł Gomółka, Katarzyna Górska, Hanna Jagielska-Len, Agnieszka Jarzemska, Ewa Jassem, Dariusz Jastrzębski, Aleksander Kania, Marek Koprowski, Rafał Krenke, Jan Kuś, Katarzyna Lewandowska, Magdalena M. Martusewicz-Boros, Kazimierz Roszkowski-Śliż, Alicja Siemińska, Krzysztof Sładek, Małgorzata Sobiecka, Karolina Szewczyk, Małgorzata Tomczak, Witold Tomkowski, Elżbieta Wiatr, Dariusz Ziora, Beata Żołnowska, Wojciech J. Piotrowski
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Pirfenidone is an antifibrotic agent approved for the treatment of idiopathic pulmonary fibrosis (IPF). The drug is available for Polish patients with IPF since 2017. The PolExPIR study aimed to describe the real-world data (RWD)
Externí odkaz:
https://doaj.org/article/819a0c653b2745e99c064475c66a7334
Publikováno v:
Medical Sciences Forum, Vol 14, Iss 1, p 42 (2022)
Cancer is a disease that has spread widely throughout the world and requires the development of new anticancer drugs. Curing cancer is a complicated process as the drugs that are used target human cells and cells that have undergone genetic changes a
Externí odkaz:
https://doaj.org/article/797ab774a15c4b4aab9fe21960caa007
Autor:
Łukasz Tomorowicz, Beata Żołnowska, Krzysztof Szafrański, Jarosław Chojnacki, Ryszard Konopiński, Ewa A. Grzybowska, Jarosław Sławiński, Anna Kawiak
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 13, p 7178 (2022)
In the search for new compounds with antitumor activity, new potential anticancer agents were designed as molecular hybrids containing the structures of a triazine ring and a sulfonamide fragment. Applying the synthesis in solution, a base of new sul
Externí odkaz:
https://doaj.org/article/1f603db029a4475da160b95c2679f6d5
Autor:
Monika Pastewska, Beata Żołnowska, Strahinja Kovačević, Hanna Kapica, Maciej Gromelski, Filip Stoliński, Jarosław Sławiński, Wiesław Sawicki, Krzesimir Ciura
Publikováno v:
Molecules, Vol 27, Iss 13, p 3965 (2022)
Sulfonamides are a classic group of chemotherapeutic drugs with a broad spectrum of pharmacological action, including anticancer activity. In this work, reversed-phase high-performance liquid chromatography and biomimetic chromatography were applied
Externí odkaz:
https://doaj.org/article/e80ded7d0fcf4212a75d42b975af059c
Autor:
Petar Žuvela, J. Jay Liu, Myunggi Yi, Paweł P. Pomastowski, Gulyaim Sagandykova, Mariusz Belka, Jonathan David, Tomasz Bączek, Krzysztof Szafrański, Beata Żołnowska, Jarosław Sławiński, Claudiu T. Supuran, Ming Wah Wong, Bogusław Buszewski
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 33, Iss 1, Pp 1430-1443 (2018)
In this work, a target-based drug screening method is proposed exploiting the synergy effect of ligand-based and structure-based computer-assisted drug design. The new method provides great flexibility in drug design and drug candidates with consider
Externí odkaz:
https://doaj.org/article/10af111bcd05473b8f60c43ce8cbd7a1
Autor:
Beata Żołnowska, Jarosław Sławiński, Mariusz Belka, Tomasz Bączek, Anna Kawiak, Jarosław Chojnacki, Aneta Pogorzelska, Krzysztof Szafrański
Publikováno v:
Molecules, Vol 20, Iss 10, Pp 19101-19129 (2015)
A series of novel N-acyl-4-chloro-5-methyl-2-(R1-methylthio)benzenesulfonamides 18–47 have been synthesized by the reaction of N-[4-chloro-5-methyl-2-(R1-methylthio) benzenesulfonyl]cyanamide potassium salts with appropriate carboxylic acids. Some
Externí odkaz:
https://doaj.org/article/cfa356af1eb141edbe3ed4a952c6af57
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 8, p 2924 (2020)
A series of novel 2-[(4-amino-6-R2-1,3,5-triazin-2-yl)methylthio]-4-chloro-5-methyl-N-(5-R1-1H-benzo[d]imidazol-2(3H)-ylidene)benzenesulfonamides 6–49 was synthesized by the reaction of 5-substituted ethyl 2-{5-R1-2-[N-(5-chloro-1H-benzo[d]imidazol
Externí odkaz:
https://doaj.org/article/20fdb5ecaa234e2b846634951498b24f